NIH-funded research R01 grant

Understanding how specific fats in skin affect barrier function and skin diseases.

Official title: Sphingolipid Biosynthesis in the Healthy and Diseased Epidermal Barrier

Funded at Virginia Commonwealth University · NIH-10981643 · Data updated 2026-11-12

This study is looking at how certain fats in your skin, called ceramides, help keep your skin healthy and how they change in conditions like atopic dermatitis, so we can better understand skin health and find new ways to help people with this common skin issue.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionVirginia Commonwealth University
NIH-funded
Lab location1 site (Richmond, United States)
Project startJuly 1, 2024
Project endJune 30, 2029
Funding year2024
Award (this year)$706,710
NIH project number1R01AR083443-01A1
Project IDNIH-10981643 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals of all ages suffering from atopic dermatitis or related skin disorders.

Less likely to help

Patients with skin conditions unrelated to epidermal barrier dysfunction may not benefit from this research.

What this research studies

This research investigates the role of unique sphingolipid ceramides in the skin's outer layer, which are crucial for maintaining a healthy epidermal barrier. It aims to understand how these ceramides are altered in conditions like atopic dermatitis, a common skin disorder. By genetically modifying the expression of specific proteins involved in ceramide production, the researchers will explore how these changes impact skin health. The study will utilize advanced techniques, including organoid cultures and animal models, to gain insights into skin barrier function.

Why it matters

Potential benefit: If successful, this research could lead to new treatments for skin conditions like atopic dermatitis by restoring or enhancing the skin barrier.

How similar studies have gone: Previous research has shown promising results in understanding skin barrier function and its relation to skin diseases, indicating that this approach has potential for success.

Where this research is happening

  • Virginia Commonwealth University
    Richmond, United States
    Active

Researchers

  • Principal investigator: Wattenberg, Brian W. — Virginia Commonwealth University
  • Study coordinator: Wattenberg, Brian W.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.